Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. Wezlana, like Stelara, is approved...
Warning Letters Issued to Two Companies for Illegally Selling Probiotic Products to Treat Diseases in Preterm Infants As part of the U.S. Food and Drug Administration’s...
NEWPORT BEACH, Calif., October 27, 2023 (Newswire.com) – Physicians for Informed Consent (PIC) has introduced two new educational documents, “Varicella (Chicken Pox): What Parents Need to Know”...
FDA authorizes updated Novavax COVID-19 vaccine for better protection against circulating variant. Learn more.
Currently, there is no FDA-approved medication for stimulant use disorder.
FDA grants marketing authorization for DNA test assessing predisposition for multiple cancer types.
FDA launches pilot program to accelerate rare disease therapies, improving communication between sponsors and FDA staff. #RareDiseaseTherapies #FDA #ClinicalTrials
FDA authorizes updated mRNA COVID-19 vaccines targeting circulating variants for enhanced protection.
Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight...
Today, the U.S. Food and Drug Administration issued a draft guidance which, once finalized, will assist cosmetics companies submitting cosmetic product facility registrations and cosmetic product...
